Abstract
Immunotherapy based on Monocyte-Derived Dendritic Cells (MDDCs) is a promising strategy for the treatment of HIV-infected individuals. Due their plasticity, using different combinations of cytokines cocktail in vitro it is possible to obtain heterogeneous MDDCs populations. In the context of HIV infection is desirable obtaining MDDC able to secrete IL-12p70 in order to induce naïve T lymp…